1-1 of 1
Basquiera Ana, MD
Close
Sort by
Journal Articles

Rapid Infusion of Rituximab (RIR) Is Well Tolerated and Can Safely Be Delivered in Patients with Lymphoproliferative Diseases.

Jorge Milone, MD, Virginia Prates, MD, Zoppegno Lucia, MD, Basquiera Ana, MD, Yantorno Sebastian, MD, Gelemur Marta, MD, Garcia Juan, MD
Journal: Blood
Blood (2007) 110 (11): 4503.
https://doi.org/10.1182/blood.V110.11.4503.4503
Published: 2007